Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Neonicotinoid exposure disrupts bumblebee nest behavior, social networks, and thermoregulation.

Crall JD, Switzer CM, Oppenheimer RL, Ford Versypt AN, Dey B, Brown A, Eyster M, Guérin C, Pierce NE, Combes SA, de Bivort BL.

Science. 2018 Nov 9;362(6415):683-686. doi: 10.1126/science.aat1598.

PMID:
30409882
2.

A novel type 2N VWF gene mutation: a case report.

Evans MS, Eyster ME.

Blood Coagul Fibrinolysis. 2018 Nov;29(7):651-652. doi: 10.1097/MBC.0000000000000761.

PMID:
30036281
3.

A cross-sectional analysis of cardiovascular disease in the hemophilia population.

Sood SL, Cheng D, Ragni M, Kessler CM, Quon D, Shapiro AD, Key NS, Manco-Johnson MJ, Cuker A, Kempton C, Wang TF, Eyster ME, Kuriakose P, von Drygalski A, Gill JC, Wheeler A, Kouides P, Escobar MA, Leissinger C, Galdzicka S, Corson M, Watson C, Konkle BA.

Blood Adv. 2018 Jun 12;2(11):1325-1333. doi: 10.1182/bloodadvances.2018018226.

4.

Development of an inhibitor in a man with mild haemophilia A.

Evans MS, Eyster ME.

Haemophilia. 2017 Sep;23(5):e473-e474. doi: 10.1111/hae.13303. Epub 2017 Jul 27. No abstract available.

PMID:
28750480
5.

Development of a novel automated screening method for detection of FVIII Inhibitors.

Evans MS, Donaldson KJ, Eyster ME.

Int J Lab Hematol. 2017 Apr;39(2):185-190. doi: 10.1111/ijlh.12601. Epub 2017 Jan 30.

PMID:
28133956
6.

Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIII.

Reding MT, Ng HJ, Poulsen LH, Eyster ME, Pabinger I, Shin HJ, Walsch R, Lederman M, Wang M, Hardtke M, Michaels LA.

J Thromb Haemost. 2017 Mar;15(3):411-419. doi: 10.1111/jth.13597. Epub 2017 Feb 22.

PMID:
27992112
7.

Moderate X-chromosome inactivation skewing underlies factor VIII activity in symptomatic carriers from a family with mild haemophilia A.

Cygan PH, Carrel L, Eyster ME.

Haemophilia. 2016 Nov;22(6):e559-e561. doi: 10.1111/hae.13083. Epub 2016 Oct 5. No abstract available.

PMID:
27704658
8.

Long term survival in persons with hemophilia and chronic hepatitis C: 40 year outcomes of a large single center cohort.

Eyster ME, Kong L, Li M, Schreibman IR.

Am J Hematol. 2016 Sep;91(9):E335-40. doi: 10.1002/ajh.24427. Epub 2016 Jul 14.

9.

Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery.

Buckner TW, Leavitt AD, Ragni M, Kempton CL, Eyster ME, Cuker A, Lentz SR, Ducore J, Leissinger C, Wang M, Key NS.

Thromb Haemost. 2016 Jul 4;116(1):42-9. doi: 10.1160/TH15-10-0802. Epub 2016 Mar 24.

PMID:
27009484
10.

Anemia and the Need for Intravenous Iron Infusion after Roux-en-Y Gastric Bypass.

Kotkiewicz A, Donaldson K, Dye C, Rogers AM, Mauger D, Kong L, Eyster ME.

Clin Med Insights Blood Disord. 2015 Jun 4;8:9-17. doi: 10.4137/CMBD.S21825. eCollection 2015.

11.

Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.

Boylan B, Rice AS, De Staercke C, Eyster ME, Yaish HM, Knoll CM, Bean CJ, Miller CH; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2015 Jun;13(6):1036-42. doi: 10.1111/jth.12902. Epub 2015 May 9.

12.

Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.

Gadalla SM, Preiss LR, Eyster ME, Goedert JJ.

J Viral Hepat. 2011 Mar;18(3):161-9. doi: 10.1111/j.1365-2893.2010.01289.x.

13.

Coping with the HIV epidemic 1982-2007: 25-year outcomes of the Hershey Haemophilia Cohort.

Eyster ME.

Haemophilia. 2008 Jul;14(4):697-702. doi: 10.1111/j.1365-2516.2008.01702.x. Epub 2008 Mar 25. No abstract available.

PMID:
18371164
14.

Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.

Melendez-Morales L, Konkle BA, Preiss L, Zhang M, Mathew P, Eyster ME, Goedert JJ.

AIDS. 2007 Jul 31;21(12):1631-6.

PMID:
17630559
15.

Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non-steroidal anti-inflammatory drugs.

Eyster ME, Asaad SM, Gold BD, Cohn SE, Goedert JJ; Second Multicenter Hemophilia Study Group.

Haemophilia. 2007 May;13(3):279-86.

PMID:
17498077
16.

HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.

Shire NJ, Horn PS, Rouster SD, Stanford S, Eyster ME, Sherman KE; Multicenter Hemophilia Cohort HCV Study Group.

Hepatology. 2006 Nov;44(5):1146-57.

PMID:
17058240
17.

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.

Tsoukas C, Eyster ME, Shingo S, Mukhopadhyay S, Giallella KM, Curtis SP, Reicin AS, Melian A.

Blood. 2006 Mar 1;107(5):1785-90. Epub 2005 Nov 15.

18.

Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia.

Zhang M, Rosenberg PS, Brown DL, Preiss L, Konkle BA, Eyster ME, Goedert JJ; Second Multicenter Hemophilia Cohort Study.

Blood. 2006 Feb 1;107(3):892-7. Epub 2005 Oct 4.

19.

Knee and hip arthroplasty infection rates in persons with haemophilia: a 27 year single center experience during the HIV epidemic.

Powell DL, Whitener CJ, Dye CE, Ballard JO, Shaffer ML, Eyster ME.

Haemophilia. 2005 May;11(3):233-9.

PMID:
15876268
20.

HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.

Qin H, Shire NJ, Keenan ED, Rouster SD, Eyster ME, Goedert JJ, Koziel MJ, Sherman KE; Multicenter Hemophilia Cohort Study Group.

Blood. 2005 Jan 15;105(2):533-41. Epub 2004 Sep 16.

21.

Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C.

Theodore D, Fried MW, Kleiner DE, Kroner BL, Goedert JJ, Eyster ME, Faust SP, Sherman KE, Kessler CM, Francis C, Aledort LM.

Haemophilia. 2004 Sep;10(5):413-21. Review.

PMID:
15357765
22.
23.

End-stage liver disease in persons with hemophilia and transfusion-associated infections.

Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC 2nd, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A.

Blood. 2002 Sep 1;100(5):1584-9.

24.
25.

Activity of HIV-1 integrases recovered from subjects with varied rates of disease progression.

Katzman M, Harper AL, Sudol M, Skinner LM, Eyster ME.

J Acquir Immune Defic Syndr. 2001 Nov 1;28(3):203-10.

PMID:
11694825
26.

Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.

Goedert JJ, Hatzakis A, Sherman KE, Eyster ME; Multicenter Hemophilia Cohort Study.

J Infect Dis. 2001 Nov 1;184(9):1202-5. Epub 2001 Sep 13.

PMID:
11598846
27.
28.

Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP.

J Cell Sci. 2001 Mar;114(Pt 6):1179-87.

29.

Characterization of high-risk HIV-1 seronegative hemophiliacs.

Salkowitz JR, Purvis SF, Meyerson H, Zimmerman P, O'Brien TR, Aledort L, Eyster ME, Hilgartner M, Kessler C, Konkle BA, White GC 2nd, Goedert JJ, Lederman MM.

Clin Immunol. 2001 Feb;98(2):200-11.

PMID:
11161976
30.

Increased liver decompensation risk with atypical hepatitis C virus antibody levels.

Goedert JJ, Hatzakis A, Maloney EM, Eyster ME.

J Infect Dis. 2000 Aug;182(2):590-4. Epub 2000 Jul 21.

PMID:
10915093
31.

Phenotypic expressions of CCR5-delta32/delta32 homozygosity.

Nguyêñ GT, Carrington M, Beeler JA, Dean M, Aledort LM, Blatt PM, Cohen AR, DiMichele D, Eyster ME, Kessler CM, Konkle B, Leissinger C, Luban N, O'Brien SJ, Goedert JJ, O'Brien TR.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):75-82.

PMID:
10534150
32.

Chronic hepatitis C virus infections in leukemia survivors: prevalence, viral load, and severity of liver disease.

Paul IM, Sanders J, Ruggiero F, Andrews T, Ungar D, Eyster ME.

Blood. 1999 Jun 1;93(11):3672-7.

33.

Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study.

Eyster ME, Sherman KE, Goedert JJ, Katsoulidou A, Hatzakis A.

J Infect Dis. 1999 May;179(5):1062-9.

PMID:
10191205
34.

Sialylated human apolipoprotein E (apoEs) is preferentially associated with neuron-enriched cultures from APOE transgenic mice.

Xu PT, Schmechel D, Qiu HL, Herbstreith M, Rothrock-Christian T, Eyster M, Roses AD, Gilbert JR.

Neurobiol Dis. 1999 Feb;6(1):63-75.

PMID:
10078974
35.

Analysis of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors.

Skinner LM, Lamers SL, Sanders JC, Eyster ME, Goodenow MM, Katzman M.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):99-110.

PMID:
9768617
36.

Thrombocytopenia in HIV-infected and uninfected hemophiliacs. Multicenter Hemophilia Cohort study.

Ehmann WC, Rabkin CS, Eyster ME, Goedert JJ.

Am J Hematol. 1997 Apr;54(4):296-300.

37.

Blood safety decisions, 1982 to 1986: perceptions and misconceptions.

Zuck TF, Eyster ME.

Transfusion. 1996 Oct;36(10):928-31.

PMID:
8863782
38.

Causes of death in haemophilia.

Ehmann WC, Eyster ME, Aledort LM, Goedert JJ.

Nature. 1995 Nov 9;378(6553):124. No abstract available.

PMID:
7477306
39.

Natural history of HIV-1 cell-free viremia.

Henrard DR, Phillips JF, Muenz LR, Blattner WA, Wiesner D, Eyster ME, Goedert JJ.

JAMA. 1995 Aug 16;274(7):554-8.

PMID:
7629984
40.

Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs.

Lederman MM, Jackson JB, Kroner BL, White GC 3rd, Eyster ME, Aledort LM, Hilgartner MW, Kessler CM, Cohen AR, Kiger KP, et al.

J Infect Dis. 1995 Jul;172(1):228-31.

PMID:
7797917
41.
42.

Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort Study.

O'Brien TR, Diamondstone L, Fried MW, Aledort LM, Eichinger S, Eyster ME, Hilgartner MW, White G, Di Bisceglie AM, Goedert JJ.

Am J Hematol. 1995 Jul;49(3):201-6.

PMID:
7604813
43.

Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups.

Ragni MV, Amato DA, LoFaro ML, DeGruttola V, Van Der Horst C, Eyster ME, Kessler CM, Gjerset GF, Ho M, Parenti DM, et al.

Blood. 1995 May 1;85(9):2337-46.

44.

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H, et al.

N Engl J Med. 1995 Mar 16;332(11):700-5.

45.

Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV. Multicenter Hemophilia Cohort Study.

Ehmann WC, Eyster ME, Wilson SE, Andes WA, Goedert JJ.

J Acquir Immune Defic Syndr. 1994 Oct;7(10):1095-8.

PMID:
7916052
47.

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status.

Seremetis SV, Aledort LM, Bergman GE, Bona R, Bray G, Brettler D, Eyster ME, Kessler C, Lau TS, Lusher J, et al.

Lancet. 1993 Sep 18;342(8873):700-3.

PMID:
8103820
48.

Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.

Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ.

J Acquir Immune Defic Syndr. 1993 Jun;6(6):602-10.

PMID:
8098752
49.

Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study.

Bray GL, Kroner BL, Arkin S, Aledort LW, Hilgartner MW, Eyster ME, Ragni MV, Goedert JJ.

Am J Hematol. 1993 Apr;42(4):375-9.

PMID:
8493988
50.

Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value.

Eyster ME, Rabkin CS, Hilgartner MW, Aledort LM, Ragni MV, Sprandio J, White GC, Eichinger S, de Moerloose P, Andes WA, et al.

Blood. 1993 Feb 1;81(3):828-34.

Supplemental Content

Loading ...
Support Center